» Articles » PMID: 1329909

Renal Size and Function After Cure of Wilms' Tumour

Overview
Journal Br J Cancer
Specialty Oncology
Date 1992 Nov 1
PMID 1329909
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Now that most patients with Wilms' tumour are cured, it is practicable to study the long-term morbidity of their treatment and use this information to reduce treatment sequelae in the future. In this study we evaluate the size and function of the remaining kidney in 53 survivors of Wilms' tumour with a mean off treatment follow-up of 13 years. There was evidence of renal dysfunction in 17 (32%), including ten (19%) with a low GFR (< 80 ml/min/1.73 m2SA), six (11%) with hypertension and five (9%) with increased urinary albumin excretion. Measurements of renal size showed 'good' renal compensatory hypertrophy in only 55% of patients. 'Good' refers to renal size of more than 2 s.d. above the mean renal length for children with two kidneys. There were no correlations between GFR, renal size, blood pressure, microalbuminuria or type of treatment. However, children less than 24 months at diagnosis and children receiving chemotherapy with radiation doses to remaining kidney of more than 1200 cGy had a worse renal prognosis. Patients whose Wilms' tumour is diagnosed in infancy should have careful long-term follow-up of renal function and size. Older patients may safely be followed up less often, unless their remaining kidney was received > 1200 cGy.

Citing Articles

Long-term kidney outcomes in survivors of Wilms tumor: a single-center retrospective cohort study.

Reinert S, Benoit S, Nagarajan R Pediatr Nephrol. 2025; .

PMID: 39779510 DOI: 10.1007/s00467-024-06624-x.


The accuracy of estimating equations for the evaluation of kidney function in adult survivors of unilateral, nonmetastatic, non-syndromic Wilms tumor: A pilot study from the St. Jude Lifetime Cohort Study.

Green D, Wang M, Krasin M, Davidoff A, Srivastava D, Jay D Pediatr Blood Cancer. 2024; 72(1):e31409.

PMID: 39502013 PMC: 11669267. DOI: 10.1002/pbc.31409.


Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer.

Wu N, Chen Y, Dieffenbach B, Ehrhardt M, Hingorani S, Howell R J Clin Oncol. 2023; 41(12):2258-2268.

PMID: 36795981 PMC: 10448933. DOI: 10.1200/JCO.22.01926.


Increased risk for kidney sequelae surrogates in survivors of Wilms tumor.

Arslan E, Saygili S, Celkan T, Kurugoglu S, Elicevik M, Camcioglu A Pediatr Nephrol. 2022; 37(10):2415-2426.

PMID: 35118543 DOI: 10.1007/s00467-022-05460-1.


Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients.

Wu N, Hingorani S Pediatr Nephrol. 2021; 36(9):2675-2686.

PMID: 33411070 PMC: 11198913. DOI: 10.1007/s00467-020-04842-7.


References
1.
Dinkel E, Britscho J, Dittrich M, Schulte-Wissermann H, Ertel M . Renal growth in patients nephrectomized for Wilms tumour as compared to renal agenesis. Eur J Pediatr. 1988; 147(1):54-8. DOI: 10.1007/BF00442612. View

2.
WIKSTAD I, Pettersson B, Elinder G, Sokucu S, Aperia A . A comparative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms' tumor and hydronephrosis. Acta Paediatr Scand. 1986; 75(3):408-14. DOI: 10.1111/j.1651-2227.1986.tb10222.x. View

3.
Dillon M . Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I. J Clin Pathol. 1975; 28(8):625-30. PMC: 475790. DOI: 10.1136/jcp.28.8.625. View

4.
Makipernaa A, KOSKIMIES O, Jaaskelainen J, Teppo A, Siimes M . Renal growth and function 11-28 years after treatment of Wilms' tumour. Eur J Pediatr. 1991; 150(6):444-7. DOI: 10.1007/BF02093729. View

5.
Jadresic L, Leake J, Gordon I, Dillon M, Grant D, Pritchard J . Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr. 1990; 117(5):717-25. DOI: 10.1016/s0022-3476(05)83327-x. View